BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NephU - ECPv6.15.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NephU
X-ORIGINAL-URL:https://nephu.org
X-WR-CALDESC:Events for NephU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20200404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20201003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20210908T200000
DTEND;TZID=Australia/Sydney:20210908T210000
DTSTAMP:20260412T131559
CREATED:20210806T211240Z
LAST-MODIFIED:20210908T194334Z
UID:10990-1631131200-1631134800@nephu.org
SUMMARY:The Utility Of Clinical Genomics In Kidney Disease: International Perspectives - Part 1
DESCRIPTION:Advances in genomic technologies in recent years have led to an increasing role for clinical genomics in nephrology practice. While this advance brings the promise of positive outcomes such as clearer diagnoses and robust information to guide clinical management\, it also opens a range of logistical\, technical\, and ethical points for the nephrologist to consider. \n\n\n\nJoin us for this informative international webinar where Professor Andrew Mallett\, nephrologist and clinical researcher (Australia)\, and Dr Hila Rasouly\, research scientist and genetic counselor (USA)\, discuss clinical genomics and its applications in kidney disease\, including genetic testing for diagnosis and prognosis and the question of determining which patients to test\, barriers to access\, global differences across healthcare landscapes\, and implications for the patient. \n\n\n\n*Professor Andrew Mallett and Dr Hila Milo Rasouly are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Dr Sundar is an employee of OPDC. \n\n\n\n				You must be logged in to register for this event.\nPlease Log In or Join Now\n				\n					Join To View\n					Already A Member? Login\n				\n			\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\nModerator\n\n\n\n 			\n 		\n		\n			Shirin Sundar\, PhD\n			Nephrology Senior Clinical & Scientific Liaison\n		\n 		\n				\n					\n					\n				\n				\n			\n 	\n\n\nLocation\n\n\n\nOnline
URL:https://nephu.org/event/the-utility-of-clinical-genomics-in-kidney-disease-international-perspectives-third-session/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2021/07/shutterstock_387637843-e1627059495498.jpg
END:VEVENT
END:VCALENDAR